Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.
Sleep apnoea is a disorder where your breathing stops and starts while you sleep with serious health implications - but how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results